Literature DB >> 8055152

Angioimmunoblastic lymphadenopathy type of T-cell lymphoma and angioimmunoblastic lymphadenopathy: a clinicopathological and molecular biological study of 13 Chinese patients using polymerase chain reaction and paraffin-embedded tissues.

J Lorenzen1, G Li, M Zhao-Höhn, C Wintzer, R Fischer, M L Hansmann.   

Abstract

The morphological classification of angioimmunoblastic lymphadenopathy (AILD) or T-cell lymphoma of AILD-type (AILD-TCL) is still a subject of considerable difficulty and controversy. The aim of the current study was to examine the value of clinical, morphological, immunohistochemical variables in paraffin-embedded tissues in predicting the clonality of the respective lesion. Fifteen lymph node biopsies derived from 13 patients from Chengdu, China, were diagnosed as AILD or AILD-TCL and included in this study. The specimens were examined using a panel of monoclonal antibodies and a scoring system of morphological features. Clonality of the paraffin-embedded material was investigated using a novel polymerase chain reaction-technique to amplify rearranged T-cell receptor (TCR)-gamma sequences. Additional experiments were carried out to investigate the presence of clonal rearrangements of the immunoglobulin heavy chain (IgH) locus. We found clonal rearrangements of the TCR-gamma locus in 9 out of 15 lymph node biopsies. In 3 patients, the predominant cell clones carried clonal IgH and TCR-gamma rearrangements whereas 1 patient with polyclonal TCR-gamma pattern displayed IgH-monoclonality. The statistical evaluation of morphological and immunohistochemical data indicated that no single variable was able significantly to predict the clonality of the lesion. Furthermore, demonstrable clonality for the TCR-gamma or the IgH loci of a lesion did not correlate with a bad clinical course. Our data correlate with findings of other studies investigating AILD-TCL in Caucasian populations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8055152     DOI: 10.1007/bf01069738

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  36 in total

1.  Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease.

Authors:  R J Lukes; B H Tindle
Journal:  N Engl J Med       Date:  1975-01-02       Impact factor: 91.245

2.  Immunoblastic lymphadenopathy, angioimmunoblastic lymphadenopathy, and IBL-like T-cell lymphoma. A spectrum of T-cell neoplasia.

Authors:  S Watanabe; Y Sato; M Shimoyama; K Minato; Y Shimosato
Journal:  Cancer       Date:  1986-11-15       Impact factor: 6.860

3.  A sensitive method of screening for dominant T cell clones by amplification of T cell gamma gene rearrangements with the polymerase chain reaction.

Authors:  R B Goudie; S N Karim; K Mills; M Alcorn; F D Lee
Journal:  J Pathol       Date:  1990-11       Impact factor: 7.996

4.  Detection of immunoglobulin gene rearrangement in B lymphoid malignancies by polymerase chain reaction gene amplification.

Authors:  M Deane; J D Norton
Journal:  Br J Haematol       Date:  1990-03       Impact factor: 6.998

5.  The rapid detection of clonal T-cell proliferations in patients with lymphoid disorders.

Authors:  K P McCarthy; J P Sloane; J H Kabarowski; E Matutes; L M Wiedemann
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

6.  Detection of Epstein-Barr virus DNA by polymerase chain reaction in lymph node biopsies from patients with angioimmunoblastic lymphadenopathy.

Authors:  H Knecht; R Sahli; P Shaw; C Meyer; E Bachmann; B F Odermatt; F Bachmann
Journal:  Br J Haematol       Date:  1990-08       Impact factor: 6.998

7.  Immunoglobulin heavy chain rearrangements in primary brain lymphomas. A study using PCR to amplify CDR-III.

Authors:  S Albrecht; J M Bruner; G K Segall
Journal:  J Pathol       Date:  1993-03       Impact factor: 7.996

8.  Recurrent chromosome abnormalities in adult T-cell lymphomas of peripheral T-cell origin.

Authors:  K Fujita; S Fukuhara; K Nasu; H Yamabe; N Tomono; Y Inamoto; C Shimazaki; H Ohno; S Doi; H Kamesaki
Journal:  Int J Cancer       Date:  1986-04-15       Impact factor: 7.396

9.  Prevalence of Epstein-Barr virus DNA in different T-cell lymphoma entities in a European population.

Authors:  G Ott; M M Ott; A C Feller; S Seidl; H K Müller-Hermelink
Journal:  Int J Cancer       Date:  1992-06-19       Impact factor: 7.396

Review 10.  Angioimmunoblastic lymphadenopathy and related disorders: a retrospective look in search of definitions.

Authors:  G Frizzera; Y Kaneko; M Sakurai
Journal:  Leukemia       Date:  1989-01       Impact factor: 11.528

View more
  6 in total

1.  Angioimmunoblastic T-cell lymphoma mimicking Crohn's disease.

Authors:  Hae Yeon Kang; Jin-Hyeok Hwang; Young Soo Park; Soo-Mee Bang; Jong Seok Lee; Jin-Haeng Chung; Haeryoung Kim
Journal:  Dig Dis Sci       Date:  2007-03-30       Impact factor: 3.199

Review 2.  [Diagnostic spectrum of reactive lymph node changes].

Authors:  S Hartmann; S Kriener; M L Hansmann
Journal:  Pathologe       Date:  2008-07       Impact factor: 1.011

3.  The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations.

Authors:  Brenton T Tan; Roger A Warnke; Daniel A Arber
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

4.  Analysis of T-cell subpopulations in T-cell non-Hodgkin's lymphoma of angioimmunoblastic lymphadenopathy with dysproteinemia type by single target gene amplification of T cell receptor- beta gene rearrangements.

Authors:  K Willenbrock; A Roers; C Seidl; H H Wacker; R Küppers; M L Hansmann
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

5.  In angioimmunoblastic T-cell lymphoma, neoplastic T cells may be a minor cell population. A molecular single-cell and immunohistochemical study.

Authors:  Klaus Willenbrock; Christoph Renné; Philippe Gaulard; Martin-Leo Hansmann
Journal:  Virchows Arch       Date:  2004-10-05       Impact factor: 4.064

6.  Diagnostic impact of molecular lineage analysis on paraffin-embedded tissue in hematolymphoid neoplasia reclassified by current WHO criteria.

Authors:  Leonard Hwan Cheong Tan; Lily-Lily Chiu; Evelyn Siew Chuan Koay
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.